Difference between revisions of "AbbVie"

From Powerbase
Jump to: navigation, search
(Affiliations)
(Lobbying firms)
 
(10 intermediate revisions by 3 users not shown)
Line 2: Line 2:
  
 
AbbVie began as the pharmaceutical leader, Abbott, which was founded in 1888 by Chicago physician, Dr. Wallace Abbott. In 2011 the companines split into [[Abbott]] and [[AbbVie]]. On January 1, 2013, AbbVie was founded as a global biopharmaceutical company with 'focus and capabilities to address some of the world’s greatest health challenges'. <ref> [http://www.abbvie.co.uk/about-us/home.html?trackingSelection=Ask About us] ''Abbvie'' company website, accessed 5 November 2014 </ref>
 
AbbVie began as the pharmaceutical leader, Abbott, which was founded in 1888 by Chicago physician, Dr. Wallace Abbott. In 2011 the companines split into [[Abbott]] and [[AbbVie]]. On January 1, 2013, AbbVie was founded as a global biopharmaceutical company with 'focus and capabilities to address some of the world’s greatest health challenges'. <ref> [http://www.abbvie.co.uk/about-us/home.html?trackingSelection=Ask About us] ''Abbvie'' company website, accessed 5 November 2014 </ref>
 +
 +
==Staff==
 +
====Board of Directors====
 +
*[[Richard A. Gonzalez]]
 +
*[[Robert J. Alpern]]
 +
*[[Roxanne S. Austin]]
 +
*[[William H.L. Burnside]]
 +
*[[Edward M. Liddy]]
 +
*[[Edward J. Rapp]]
 +
*[[Roy S. Roberts]]
 +
*[[Glenn F. Tilton]]
 +
*[[Frederick H. Waddell]]
 +
 +
====AbbVie Leadership====
 +
*[[RIchard A. Gonzalez]] - Chairman of the Board and chief executive officer
 +
*[[Laura J. Schumacher]] - Executive vice president, business development, external affairs and general counsel
 +
*[[William J. Chase]] - Executive vice president, chief financial officer
 +
*[[Carlos Alban]] - Executive vice president, commercial operations
 +
*[[Michael E. Severino]] - Executive vice president, research & development and chief scientific officer
 +
*[[Timothy J. Richmond]] - Senior vice president, human resources
 +
*[[Azita Saleki- Gerhardt]] - Senior vice president, operations
 +
*[[Karen Hale]] - Vice president, chief ethics and compliance officer <ref> [http://www.abbvie.com/about-us/leadership/home.html Abbvie Leadership] ''abbvie'', accessed 8 April 2015 </ref>
 +
 +
*[[Tony Sampson]] - Director of government affairs
  
 
==Affiliations==
 
==Affiliations==
AbbVie is currently a donor to the [[Science Media Centre]] according to the SMC. <ref>SMC, [http://www.sciencemediacentre.org/about-us/funding/ Funding], accessed 29 September 2013. See also [[Science Media Centre - Funding]]</ref>
+
AbbVie is a donor to the [[Science Media Centre]]. <ref>SMC, [http://www.sciencemediacentre.org/about-us/funding/ Funding], accessed 29 September 2013. See also [[Science Media Centre - Funding]]</ref>
 +
*[[The Corporate Capture of the NHS]]
  
 
==Lobbying firms==
 
==Lobbying firms==
 
*[[Luther Pendragon]]<ref> [http://www.appc.org.uk/members/register/register-profile/?company=Luther%20Pendragon Register 1st September 2014 - 30th November 2014] ''APPC'', accessed 28 January 2015 </ref>
 
*[[Luther Pendragon]]<ref> [http://www.appc.org.uk/members/register/register-profile/?company=Luther%20Pendragon Register 1st September 2014 - 30th November 2014] ''APPC'', accessed 28 January 2015 </ref>
 
*[[JMC Partners LLP]]<ref> [http://www.appc.org.uk/members/register/register-profile/?company=JMC%20Partners%20LLP Register 1st September 2014 - 30th November 2014] ''APPC'', accessed 29 January 2015 </ref>
 
*[[JMC Partners LLP]]<ref> [http://www.appc.org.uk/members/register/register-profile/?company=JMC%20Partners%20LLP Register 1st September 2014 - 30th November 2014] ''APPC'', accessed 29 January 2015 </ref>
 +
*[[Chambré Public Affairs LLP]] <ref>[http://www.appc.org.uk/members/register/register-profile/?company=Chambre%20Public%20Affairs%20LLP Chambre Public Affairs Register Dec15-Feb16], ''APPC'', accessed 15 April 2016</ref>
 +
*[[Incisive Health]] <ref>[https://registerofconsultantlobbyists.force.com/CLR_Public_Profile?id=00124000005zm31AAA Incisive Health profile 2016], ''Registrar of consultant lobbyists'', accessed 3 May 2016</ref>
  
 
==Contact==
 
==Contact==
 
Web site: www.abbvie.co.uk
 
Web site: www.abbvie.co.uk
 
Address: AbbVie Ltd, Abbott House, Vanwall Business Park, Vanwall Road, Maidenhead, Berkshire, SL6 4XE, UK
 
Address: AbbVie Ltd, Abbott House, Vanwall Business Park, Vanwall Road, Maidenhead, Berkshire, SL6 4XE, UK
 +
 +
==Resources==
 +
See: [[The Corporate Capture of the NHS]]
 +
*Tamasin Cave, [http://www.spinwatch.org/index.php/issues/lobbying/item/5759-the-privatising-cabal-at-the-heart-of-our-nhs The privatising cabal at the heart of our NHS] ''Spinwatch'', 1 April 2015.
  
 
== Notes ==
 
== Notes ==
 
<references/>
 
<references/>
  
[[Category:Science Media Centre]]
+
[[Category:Science Media Centre]][[Category:Health]]

Latest revision as of 09:54, 3 May 2016

AbbVie is a research-based biopharmaceutical company.

AbbVie began as the pharmaceutical leader, Abbott, which was founded in 1888 by Chicago physician, Dr. Wallace Abbott. In 2011 the companines split into Abbott and AbbVie. On January 1, 2013, AbbVie was founded as a global biopharmaceutical company with 'focus and capabilities to address some of the world’s greatest health challenges'. [1]

Staff

Board of Directors

AbbVie Leadership

Affiliations

AbbVie is a donor to the Science Media Centre. [3]

Lobbying firms

Contact

Web site: www.abbvie.co.uk Address: AbbVie Ltd, Abbott House, Vanwall Business Park, Vanwall Road, Maidenhead, Berkshire, SL6 4XE, UK

Resources

See: The Corporate Capture of the NHS

Notes

  1. About us Abbvie company website, accessed 5 November 2014
  2. Abbvie Leadership abbvie, accessed 8 April 2015
  3. SMC, Funding, accessed 29 September 2013. See also Science Media Centre - Funding
  4. Register 1st September 2014 - 30th November 2014 APPC, accessed 28 January 2015
  5. Register 1st September 2014 - 30th November 2014 APPC, accessed 29 January 2015
  6. Chambre Public Affairs Register Dec15-Feb16, APPC, accessed 15 April 2016
  7. Incisive Health profile 2016, Registrar of consultant lobbyists, accessed 3 May 2016